The future role of AI in cardiology
The clinical trial examining the use of AI for cardiac imaging, known as the EVAREST Study, is being led by the Radcliffe Department of Medicine at Oxford University and has recruited over 8000 patients for the study so far. The study seeks to track how the use of imaging biomarkers on heart scans can improve the accuracy of identifying narrowed heart arteries which can cause ischemic heart disease, also known as coronary heart disease.
“The future role of Artificial Intelligence (AI) in cardiology is fascinating. It offers advanced sensitivity and specificity for interpreting stress echo imaging that doctors can then use to more accurately measure signs of ischemia on the heart. It’s a great adjunct and tool for the clinician to use when making a decision about a patient’s treatment.”
Sparking an interest in cardiology
It was while on a second-year placement in the outback regional town of Charters Towers that Lily’s interest in cardiology first developed, as she had the opportunity to be involved with the hospital’s cardiology clinic and the visiting cardiologist consultant.
“On that placement I learnt that by picking up on something otherwise missed, you could potentially save a life,” said Lily. “For example, if a scan shows blood vessels that are almost closed off and it is not noticed, then these patients are at real risk of not getting the right treatment which could be life-threatening.”
Another benefit of Lily’s research gap year was the opportunity to experience the UK health system, especially as Northwick Park Hospital is a major acute, general hospital and also a teaching hospital.
“It has been interesting comparing the Northwick interns’ medical training to my experience at JCU. It has made me appreciate the incredible breadth of what JCU students learn when they are on their rural placements; what we encounter in those settings and the responsibilities that we are given.”